| Jeffrey R Jones, DO | |
|
2821 N Van Buren St Ste B, Enid, OK 73703-1729 | |
| (580) 213-9012 | |
| (580) 213-9795 |
| Full Name | Jeffrey R Jones |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 40 Years |
| Location | 2821 N Van Buren St Ste B, Enid, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295735355 | NPI | - | NPPES |
| 100176940A | Medicaid | OK | |
| P00069156 | Other | OK | RAILROAD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2461 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Bass Baptist Health Center | Enid, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integris Bass Baptist Health Center | 0345151981 | 23 |
News Archive
In this interview, News-Medical speaks to Dr. Howard Hu about his latest research into cadmium and how it could be causing more severe pneumonia infections.
The use of medication to treat attention deficit hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study led by researchers at Indiana University.
Researchers from the University of Southampton have helped construct an online interactive world map which gives stark facts and figures about the health of women during pregnancy, childbirth and following the birth of their child.
Oncolytics Biotech Inc. announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer.
Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.
› Verified 7 days ago
| Entity Name | Integris Bass Baptist Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124029293 PECOS PAC ID: 0345151981 Enrollment ID: O20031103000717 |
News Archive
In this interview, News-Medical speaks to Dr. Howard Hu about his latest research into cadmium and how it could be causing more severe pneumonia infections.
The use of medication to treat attention deficit hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study led by researchers at Indiana University.
Researchers from the University of Southampton have helped construct an online interactive world map which gives stark facts and figures about the health of women during pregnancy, childbirth and following the birth of their child.
Oncolytics Biotech Inc. announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer.
Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.
› Verified 7 days ago
| Entity Name | Integris Ambulatory Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750333936 PECOS PAC ID: 2365408465 Enrollment ID: O20041209000354 |
News Archive
In this interview, News-Medical speaks to Dr. Howard Hu about his latest research into cadmium and how it could be causing more severe pneumonia infections.
The use of medication to treat attention deficit hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study led by researchers at Indiana University.
Researchers from the University of Southampton have helped construct an online interactive world map which gives stark facts and figures about the health of women during pregnancy, childbirth and following the birth of their child.
Oncolytics Biotech Inc. announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer.
Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey R Jones, DO 5300 N Independence Ave, Oklahoma City, OK 73112-5556 Ph: (580) 213-9012 | Jeffrey R Jones, DO 2821 N Van Buren St Ste B, Enid, OK 73703-1729 Ph: (580) 213-9012 |
News Archive
In this interview, News-Medical speaks to Dr. Howard Hu about his latest research into cadmium and how it could be causing more severe pneumonia infections.
The use of medication to treat attention deficit hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study led by researchers at Indiana University.
Researchers from the University of Southampton have helped construct an online interactive world map which gives stark facts and figures about the health of women during pregnancy, childbirth and following the birth of their child.
Oncolytics Biotech Inc. announced today that it has entered into an agreement whereby the NCIC Clinical Trials Group (CTG) at Queen's University in Kingston, Ontario, will sponsor and conduct a randomized Phase II study of REOLYSIN in patients with advanced or metastatic colorectal cancer.
Renowned national and international leaders in diabetes prevention, treatment and research will descend on Philadelphia for the Second Annual Diabetes Symposium: New Advances and Innovations, a one-day symposium on advancing patient care at the intersection of diabetes and cardiovascular disease, cancer, sexual health and new this year, physicians and diabetes educators will address the latest advances in managing obesity in the diabetic patient.
› Verified 7 days ago
Dr. Michael B Scott, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 915 E Garriott Rd, Ste B, Enid, OK 73701 Phone: 580-233-5544 Fax: 580-233-7895 | |
Dr. David Matousek, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 330 S 5th St Ste 302, Enid, OK 73701 Phone: 580-234-3320 | |
David Barnard, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 527 Gott Rd, Enid, OK 73705 Phone: 580-213-6239 | |
Aaron Scott Sizelove, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 915 E Garriott Rd, Suite B, Enid, OK 73701 Phone: 580-213-9745 Fax: 580-234-5749 | |
Dr. Garrett Shelton, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3517 W Owen K Garriott Rd, Suite Four, Enid, OK 73703 Phone: 580-233-5553 | |
Dr. Chang Liu Lipinski, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 527 Gott Rd, Enid, OK 73705 Phone: 580-213-5153 Fax: 580-213-7959 | |
Dr. Seth H. Switzer, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 302 N Independence St Ste 700, Enid, OK 73701 Phone: 580-249-3795 Fax: 580-234-3299 |